pyrroles has been researched along with Hypertrophy in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaikwad, AN; Goand, UK; Gupta, A; Gupta, S; Kumar, D; Rajan, S; Shankar, K; Srivastava, A; Srivastava, AK; Varshney, S; Vishwakarma, AL | 1 |
| Bansal, A; Bhardwaj, V; Chattopadhyay, P; Nehra, S; Saraswat, D | 1 |
| Jaimes, EA; Raij, L; Tian, R; Zhou, MS | 1 |
| Han, SH; Kang, HY; Kang, SW; Kim, CH; Kim, S; Lee, MJ; Lee, SH; Moon, SJ; Nam, BY; Oh, HJ; Paeng, J; Park, JT; Yoo, TH | 1 |
| Cho, SN; Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Kim, HS; Lin, MQ; Ryu, Y; Yu, SY | 1 |
| Advani, A; Cox, AJ; Gilbert, RE; Kelly, DJ; Wiggins, KJ; Zhang, Y | 1 |
| Chiu, CZ; Shyu, KG; Wang, BW | 1 |
| Desiderio, MA; Perin, A; Sessa, A | 1 |
| Creed, KE; Malmgren, A | 1 |
| Andersson, KE; Andersson, PO; Fovaeus, M; Malmgren, A; Sjögren, C | 1 |
| Andersson, KE; Andersson, PO; Malmgren, A; Sjögren, C | 1 |
11 other study(ies) available for pyrroles and Hypertrophy
| Article | Year |
|---|---|
Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue.
Topics: Adipose Tissue; Animals; Energy Metabolism; Glucose; Homeostasis; Hypertrophy; Inflammation; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Specificity; Phenylpropionates; Pyrroles | 2018 |
Nanocurcumin-pyrroloquinoline formulation prevents hypertrophy-induced pathological damage by relieving mitochondrial stress in cardiomyocytes under hypoxic conditions.
Topics: Animals; Cell Survival; Cells, Cultured; Curcumin; Hypertrophy; Hypertrophy, Right Ventricular; Hypoxia; Male; Mitochondria; Myocytes, Cardiac; Pyrroles; Quinolines; Rats; Rats, Sprague-Dawley | 2017 |
Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.
Topics: Amlodipine; Animals; Antihypertensive Agents; Aorta; Atorvastatin; Blood Pressure; C-Reactive Protein; Calcium Channel Blockers; Chemokine CCL2; Disease Models, Animal; Drug Therapy, Combination; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy; Male; Nitric Oxide Synthase Type III; Pyrroles; Rats, Inbred Dahl; Scavenger Receptors, Class E; Sodium Chloride, Dietary; Superoxides; Time Factors; Vasodilation | 2014 |
Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Aspartic Acid; Caspase 3; Caspase Inhibitors; Cells, Cultured; Diabetes Mellitus, Experimental; ErbB Receptors; Gene Expression; Hypertrophy; Kidney Glomerulus; Male; Mice; Podocytes; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rats, Sprague-Dawley; Streptozocin | 2015 |
Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Cycle Proteins; Cell Nucleus; Cell Proliferation; Cells, Cultured; DNA; GATA6 Transcription Factor; Gene Expression; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Hypertension; Hypertrophy; Kidney; Male; Mice; Muscle, Smooth, Vascular; Phosphorylation; Pyrroles; Repressor Proteins; Vascular Remodeling | 2016 |
Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
Topics: Albuminuria; Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; ErbB Receptors; Female; Hypertrophy; Kidney; Mice; Podocytes; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Rats; Rats, Transgenic; Renin; WT1 Proteins | 2011 |
Use of atorvastatin to inhibit hypoxia-induced myocardin expression.
Topics: Animals; Animals, Newborn; Atorvastatin; Blotting, Western; Cells, Cultured; Electrophoretic Mobility Shift Assay; Extracellular Signal-Regulated MAP Kinases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy; Hypoxia; Myocytes, Cardiac; Nuclear Proteins; Pyrroles; Rats; Rats, Wistar; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Trans-Activators | 2012 |
Induction of diamine oxidase activity in rat kidney during compensatory hypertrophy.
Topics: Acetaldehyde; Amine Oxidase (Copper-Containing); Animals; Cycloheximide; Dactinomycin; Enzyme Induction; Hypertrophy; Kidney; Male; Nephrectomy; Phenobarbital; Polyamines; Putrescine; Pyrroles; Rats; Rats, Inbred Strains | 1982 |
The effect of cromakalim on the electrical properties of and [86Rb+] efflux from normal and hypertrophied rat bladder.
Topics: Action Potentials; Animals; Benzopyrans; Calcium Channel Blockers; Cromakalim; Electrophysiology; Female; Hypertrophy; In Vitro Techniques; Membrane Potentials; Microelectrodes; Muscle Contraction; Muscle, Smooth; Nifedipine; Parasympatholytics; Pyrroles; Rats; Rats, Sprague-Dawley; Rubidium; Rubidium Radioisotopes; Urinary Bladder | 1993 |
Effects of cromakalim (BRL 34915) and pinacidil on normal and hypertrophied rat detrusor in vitro.
Topics: Animals; Benzopyrans; Carbachol; Cromakalim; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guanidines; Hypertrophy; In Vitro Techniques; Muscle Contraction; Pinacidil; Potassium; Pyrroles; Rats; Rats, Inbred Strains; Urinary Bladder; Vasodilator Agents | 1990 |
Effects of pinacidil and cromakalim (BRL 34915) on bladder function in rats with detrusor instability.
Topics: Animals; Benzopyrans; Cromakalim; Female; Guanidines; Hypertrophy; Pinacidil; Pyrroles; Rats; Rats, Inbred Strains; Reference Values; Urethral Obstruction; Urinary Bladder; Urinary Bladder Diseases | 1989 |